echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Hunan cancels the restriction of drug distribution enterprises winning the bid in public hospitals

    Hunan cancels the restriction of drug distribution enterprises winning the bid in public hospitals

    • Last Update: 2016-12-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: 39 health.com.cn on December 20, 2016, Hunan provincial medicine centralized procurement management platform issued the letter of Hunan Provincial Health and Family Planning Commission on canceling the restrictions on the number of distribution rights of winning drugs in public hospitals It is clearly pointed out that the number of winning drugs in public hospitals per city and state is up to 5 (big infusion 8) The distribution right limit of (home) will be cancelled The health and family planning departments of each state and city, the medical and health institutions directly under the Ministry and province are requested to urge the drug production and distribution enterprises to adjust and improve the distribution relationship in time to ensure the clinical drug demand of public medical institutions It is pointed out in the document that since the implementation of the new round of drug centralized procurement winning results, Hunan Provincial Health and Family Planning Commission has received oral or written responses from many health and family planning departments and public hospitals in succession: due to the remote location, the production enterprises of the winning enterprises are limited by the distribution right, and the distribution right is not given to the main distribution enterprises or public hospital centralized distribution enterprises, resulting in the hospital's clinical medication The need cannot be met, forcing the department hospital to violate the same price outside the network before winning the bid with the same product specification of the manufacturer In order to truly use the market to play a decisive role in resource allocation, safeguard the legitimate rights and interests of the public in drug use, and coordinate with the overall promotion of the "two ticket system" of drug purchase and sale in Hunan Province, the health and Family Planning Commission of Hunan Province decided to cancel the restrictions on drug distribution rights in public hospitals As for the policy revision of the health and Family Planning Commission of Hunan Province, the industry generally believes that the new policy is more grounded and practical However, some analysts pointed out that the introduction of the new deal does not mean the loss of regulation, but also must choose enterprises with distribution qualification to implement The dispute over the priority of distributors is the new policy of strictly implementing the "two ticket system" in the field of pharmaceutical circulation Many provinces and cities, such as Hunan, Shaanxi, Anhui and so on, have launched to give the priority of distributors to medical institutions, which has also aroused heated discussion in the industry "If the number of distribution enterprises is limited, the two ticket system cannot be implemented In the current form of drug distribution, it is impossible for several drug distribution enterprises to fully cover the requirements of all medical institutions " A person in charge of a pharmaceutical enterprise, who didn't want to be named, told 39 Pharma Jun that if the medical institutions choose the distributors first, then for the manufacturing enterprises, they should follow the hospital to choose, and the channels may also change The practice of restricting the distribution right only considers the idea of the hospital, without considering the needs of the manufacturing enterprises, so it can't be implemented at all Further, the increase in drug distribution can greatly meet the clinical drug demand and increase the market competition In order to compete for more market share, many distributors will try their best to expand their channel construction, improve their service quality, and finally form the mechanism of survival The implementation of "two vote system" should be flexible and flexible In April 2016, the health and Family Planning Commission of Hunan Province reviewed and approved the pilot plan for deepening the comprehensive reform of the medical and health system in Hunan Province, marking that the province is about to enter the "two vote system era" In the aspect of drug supply and distribution, the traceability mechanism of drug ex factory price information will be established, and the "two ticket system" of one invoice from production to circulation and one invoice from circulation to medical institutions will be implemented In principle, the winning enterprise shall entrust the drug distributor to distribute or directly distribute the drugs In the industry, Hunan's "two vote system" is very clear, and roughly consistent with the national thinking Strictly control the number of enterprises in the field of drug circulation, and there are even rumors that Hunan may have a "one vote system" In the view of the industry, the implementation of the "two vote system" means that enterprises can strengthen cooperation with businesses, flatten channels and quickly make products reach the terminals At the same time, it can improve the operation quality and channel distribution quality of enterprises, and make industrial enterprises have more market management added value Such cooperation is called strong alliance However, due to China's vast territory and relatively scattered population, it is difficult to achieve "two ticket system" in drug distribution in underdeveloped areas Some analysts pointed out that the main goal of the "two vote system" is to make the price transparent and change the cost settlement mode The original intention is to squeeze the water in the middle, so as long as this goal is achieved, the specific rules can be flexibly mastered.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.